-
1 Comment
Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited is currently in a long term uptrend where the price is trading 15.4% above its 200 day moving average.
From a valuation standpoint, the stock is 100.0% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 0.4.
Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited's total revenue sank by 0.7% to $15B since the same quarter in the previous year.
Its net income has increased by 772.4% to $256M since the same quarter in the previous year.
Finally, its free cash flow fell by 104.2% to $-153M since the same quarter in the previous year.
Based on the above factors, Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited gets an overall score of 3/5.
| ISIN | CNE100000387 |
|---|---|
| Exchange | F |
| CurrencyCode | EUR |
| Sector | Healthcare |
| Industry | Medical Distribution |
| Market Cap | 3B |
|---|---|
| PE Ratio | 7.87 |
| Target Price | None |
| Dividend Yield | 47.% |
| Beta | 0.35 |
Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited engages in the pharmaceutical and healthcare industry in the People's Republic of China and internationally. The company operates through Modern Chinese Medicine Business, Chemical Pharmaceutical Technology Business, Natural Beverage Business, Pharmaceutical Commercial Business, and Other segments. It is involved in the research, development, manufacturing, and sale of chemical drugs, chemical raw materials, and chemical raw material intermediates; and research, development, production, and sale of health products; and wholesale, retail, and import export of Western medicines, traditional Chinese medicines, and medical devices. The company also offers bio-innovation, consumer health, and medical services; Xiaochaihu granules; Qingkailing and Baoji, Xia Sangju product series; Angong Niuhuang, Zishen Yutai, Xiaoke, Huatuo Zaizao, Zhuangyao Jianshen, and Shujin Jianyao pills; compound Danshen and Naoxinqing tablet series; Banlangen, Compound Banlangen, and Dashen Kouyanqing granules series; and honey-processed Chuanbei and Shedan Chuanbei loquat syrup. In addition, it provides antibacterial and anti-inflammatory drugs, andrological drugs, and analgesics and antipyretics; Wanglaoji herbal tea, Ciningji series, Lixiaoji series, and Yerou coconut milk; and advertising services. Further, the company engages in the medical research industry; technology services industry; leasing and business services; and scientific research and technical services industry. It operates through hospitals, community healthcare facilities, and retail outlets through distributors and agents. The company was formerly known as Guangzhou Pharmaceutical Company Limited and changed its name to Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited in August 2013. Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited was incorporated in 1997 and is based in Guangzhou, China.
Learn MoreHere's how to backtest a trading strategy or backtest a portfolio for GU5.F using our backtest tool. PyInvesting provides the backtesting software for you to backtest your investment strategy. Our backtest software is written using Python code and allows you to backtest stock, backtest etf, backtest options, backtest crypto and backtest forex online. Our backtesting Python framework is highly robust and gives you a realistic simulation of how your strategy would have performed in the past using backtest data.
© PyInvesting 2026
